Jay S. Duker, MD, takes reins as CEO of EyePoint from Nancy S. Lurker
Click Here to Manage Email Alerts
Key takeaways:
- Jay S. Duker, MD, has been appointed as CEO of EyePoint.
- Nancy S. Lurker has transitioned to executive vice chair of the board of directors.
Jay S. Duker, MD, has been appointed as CEO of EyePoint Pharmaceuticals, and Nancy S. Lurker has transitioned from CEO to executive vice chair of the board of directors, according to a press release.
Duker joined EyePoint in 2016 as an independent member of the company’s board of directors and transitioned to part-time chief strategic scientific officer in 2020, followed by full-time chief operating officer in 2021. He assumed the role of president earlier this year.
“I am honored to become chief executive officer of EyePoint at this exciting juncture as we advance our potentially transformational treatment options for a variety of eye diseases and focus on expanding our pipeline by leveraging the sustained delivery capability of our Durasert E technology,” Duker said in the release. “As a physician dedicated to improving outcomes in retinal disease, I am incredibly passionate about EyePoint’s mission of bringing innovative therapies to patients at risk of losing their sight. I look forward to continuing to work with our top-tier executive team and world-class board of directors to build on our recent achievement.”
Lurker served as CEO of EyePoint for 7 years and oversaw the advancement of EYP-1901 into two phase 2 trials and the sale of the commercial rights to Yutiq (fluocinolone acetonide intravitreal implant) 0.18 mg.
“It has been a privilege to lead the growth of EyePoint into a best- in-class leader in sustained ocular drug delivery, advancing first-in-class therapeutics,” Lurker said in the release. “With the transformation of EyePoint into a pure play drug development company, a compelling clinical pipeline, and recent financial and clinical achievements that put EyePoint in a position of strength, this is the right time to move into a new role. I have never been more excited about our potential and am deeply confident in the company’s future under Jay’s leadership.”
Read more about
Click Here to Manage Email Alerts